Sign inJoin waitlistJoin the waitlist

Peter C. Everett

Assistant Professor of Medicine · Chobanian and Avedisian School of Medicine

Credentials: · · ·

History

Chobanian and Avedisian School of Medicine
Present

Research

Development of a three-dimensional treatment planning system based on computed tomographic data
Case report · International Journal of Oral and Maxillofacial Surgery · 2002 · 107 citations
Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck
Clinical Cancer Research · 2022 · 95 citations
Induction of erythroid differentiation in human erythroleukemia cells by depletion of malic enzyme 2
PLoS ONE · 2010 · 52 citations

Kei Suzuki
4 papers
Kimberley Mak
4 papers
Umit Tapan
4 papers
Minh Truong
3 papers
Aiven Dyer
2 papers
ES
Edward Seldin
2 papers
Leonard Kaban
2 papers
Michael Millis
2 papers
Scharukh Jalisi
2 papers
Adam Lerner
1 paper
Alexander Moeller
1 paper · 1 as a resident
AS
Andrew Salama
1 paper

Clinical trials

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2029
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
Site PI · Recruiting · Phase 4
Coherus Oncology, Inc.
2024–2027
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Site PI · Recruiting · Phase 2
NRG Oncology
2023–2032